Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: celeryroot.com who wrote (14914)	2/12/1998 6:31:00 PM
From: Arthur Radley	Respond to of 32384

I don't know where he is coming from questioning the insider ownership in the stock. This is not uncommon since most startup biotechs have to get huge amounts of money from investors and they pretty much have to let the financiers get the shares. This makes sense, since they are putting up the money and it will be several years before they get a return on their investment. I have a best friend who co-founded a oncology management company and with the stock he controls is well within the range of what LGND officers control. Their market cap is well into the billions now but for years they struggle to grow the company. Don't cry for him, he is a multi-millionaire now, but for years it was only hard work and a hope that things would workout.